What is Bethanechol?
Bethanechol chloride is a synthetic cholinergic agent (direct-acting muscarinic receptor agonist) structurally related to acetylcholine that stimulates parasympathetic activity, primarily used to enhance bladder detrusor muscle contraction and gastrointestinal smooth muscle motility 1.
Mechanism and Clinical Use
Bethanechol works by directly stimulating muscarinic receptors without significant nicotinic activity at therapeutic doses. It enhances:
- Detrusor smooth muscle contraction in the bladder
- Gastrointestinal motility through increased smooth muscle contractility
- Parasympathetic activity throughout the gut 2
The drug is available in oral formulations (5 mg, 10 mg, 25 mg, or 50 mg tablets) and is typically prescribed for conditions involving bladder atony, urinary retention, incomplete bladder emptying, and neurogenic bladder 1, 3.
Absolute Contraindications
Bethanechol is absolutely contraindicated in the following conditions 1:
Cardiovascular Conditions:
- Pronounced bradycardia or hypotension
- Vasomotor instability
- Coronary artery disease
Gastrointestinal Conditions:
- Peptic ulcer disease
- Mechanical gastrointestinal obstruction
- Recent gastrointestinal resection and anastomosis
- Questionable integrity of the gastrointestinal wall
- Spastic gastrointestinal disturbances
- Acute inflammatory lesions of the gastrointestinal tract
- Peritonitis
Urological Conditions:
- Bladder neck obstruction
- Questionable integrity of the bladder wall
- Recent urinary bladder surgery
Other Medical Conditions:
- Hypersensitivity to bethanechol chloride
- Hyperthyroidism
- Latent or active bronchial asthma
- Epilepsy
- Parkinsonism
- Marked vagotonia
Important Clinical Caveats
A critical pitfall is prescribing bethanechol in neurogenic bladder conditions with urethral sphincter hypertonicity 4. In suprasacral spinal cord lesions, the drug is contraindicated because increased detrusor contraction against a hypertonic sphincter worsens bladder dysfunction. Bethanechol requires partial integrity of the micturition reflex to be effective 4, 5.
Side Effects to Monitor:
Common adverse events include nausea, abdominal distension, and abdominal cramping (occurring in approximately 29% of patients), though these are generally manageable without medical intervention 6. At higher doses, weak nicotinic stimulation may paradoxically cause noradrenaline release and urethral smooth muscle contraction 4.
Rare but Serious Reactions:
Acute dystonic reactions have been reported, particularly in pediatric patients, representing a cholinergic-mediated extrapyramidal effect 7.
Current Clinical Context
Despite limited evidence for clinical efficacy, bethanechol continues to be prescribed primarily by urologists (92%) for elderly women with detrusor atony and urinary retention, typically as a continued medication for chronic conditions 3. However, recent guidelines have deprioritized bethanechol, with the 2025 AGA gastroparesis guidelines explicitly excluding direct-acting cholinergic agonists like bethanechol from their comprehensive treatment evaluation 8, and the 2020 guidelines on intestinal dysmotility noting that parasympathomimetics are "rarely used because of both their gastrointestinal and cardiovascular side effects" 2.